![[IPWatchdog Logo]](https://ipwatchdog.com/wp-content/themes/IPWatchdog%20-%202023/assets/images/temp/logo-small@2x.png){kind=logo}
Squires Orders Appeals Panel to Review PTAB Rehearing Decision Reversing ODP Rejections
The U.S. Patent and Trademark Office (USPTO) announced Thursday that it will convene an Appeals Review Panel (ARP) to examine the issues raised by a 2025 rehearing decision of the Patent Trial and Appeal Board (PTAB) with respect to obviousness-type double patenting (ODP). In Ex Parte Baurin, issued on December 18, 2025, the PTAB denied an examiner’s request for reconsideration of the Board’s November 8, 2024, decision reversing the examiner’s ODP rejections of several claims of US Application No. 17/135,529, directed to antibody-like binding proteins. The Board found that the reference patent the examiner relied upon for its ODP analysis, U.S. Patent No. 10,882,922, was not a proper ODP reference because it was later filed and later expiring than the application in the present case.
Eileen McDermott
4 hours ago
0
![[Advertisement]](https://ipwatchdog.com/wp-content/uploads/2025/11/LIVE-2026-banner-regular-price-1500x500-rev1.jpg)
Other Barks & Bites for Friday, March 6: WIPO Issues PCT Filing Study; CAFC Affirms Use of Unaccused Devices in Royalty Determination; USTR Notorious Markets List Highlights Live Sports Piracy
This week in Other Barks & Bites: the World Intellectual Property Organization releases a study showing a slight uptick in international patent filings for the second straight year; Moderna stock rises nearly 10% on news of its patent infringement settlement over COVID-19 vaccine technology; the Federal Circuit says there is no per se rule against consideration of noninfringing features in a reasonable royalty determination; and more.
Steve Brachmann
6 hours ago
0
USTR Report May Stem Trade Partners’ Weak-Patent Agenda
China, the EU and the UK are quietly rewriting the rules on standard-essential patents (SEPs) in ways that strip value from U.S. innovators’ technology. As the Office of the U.S. Trade Representative (USTR) finalizes its 2026 Special 301 Report, Washington has a rare chance to call out these trading partners for turning global licensing into a government-managed exercise that drives royalty rates below market value.
James Edwards
March 5, 2026, 04:15 PM
1
When Policy Narratives Override the Facts: A Response to Recent Commentary on My PTAB Case
In a recent Substack post discussing Patent Trial and Appeal Board (PTAB) policy and current U.S. Patent and Trademark Office (USPTO) reforms, former USPTO Deputy Solicitor Thomas Krause referenced my PTAB case as part of his broader argument. Because my case was cited in that discussion, the factual record matters… My case does not support the claim that the PTAB primarily exists to correct examiner errors or clean up patents issued over missed prior art.
Molly Metz
March 5, 2026, 12:15 PM
7
Inside the PTAB Reset: Practical Fixes for a Reengineered PTAB | IPWatchdog Unleashed
In this episode of IPWatchdog Unleashed, I speak with Matt Johnson, Co-Chair of the PTAB Practice at Jones Day, and we take an in-depth look at the Patent Trial and Appeal Board (PTAB) nearly a decade and a half after its launch. Johnson and I discuss the ongoing PTAB reset at the United States Patent and Trademark Office (USPTO) and suggest practical fixes for a better, reengineered PTAB. The majority of the conversation is devoted to concrete, targeted reform suggestions that would lead to a better functioning PTAB and more streamlined IPR review system. Instead of abstract complaints, Johnson proposes narrowing PGR estoppel to encourage early challenges, moving IPR estoppel to the point of institution to eliminate gamesmanship, separating institution decisions from full merits adjudication to reduce confirmation bias, and rethinking quiet-title concepts to better align notice to implementers with settled expectations of patent owners.
Gene Quinn
February 3, 2026, 03:29 PM
2
Strengthening IP Enables Human Creativity and Economic Mobility | IPWatchdog Unleashed
In this week’s episode of IPWatchdog Unleashed, I speak with Megan Carpenter, who just recently stepped down as Dean of UNH Franklin Pierce School of Law after more than eight years. Our conversation was part personal journey and business philosophy together with a candid assessment of the IP ecosystem. We tackle emerging issues, including AI’s impact on legal practice and education. And we discuss the role of IP as essential to sustaining innovation in a rapidly evolving global economy, and fostering human creativity, innovation, and economic mobility.
Gene Quinn
January 27, 2026, 11:56 AM
1
Patent Reset: 2025’s Pivotal Moments and What Comes Next
As we wind down 2025 it is time to reflect on the year that was, and what the future will bring. This year was punctuated by a structural reset for the U.S. patent system. What unfolded was not just incremental reform, but a coordinated shift driven by leadership change, policy realignment, economic pressure, and accelerating adoption of AI—all converging to reshape how patents are examined, challenged, monetized, and managed. This week on IPWatchdog Unleashed we explore the monumental changes and the biggest trends that impacted the patent and innovation industry during 2025, and which will play an important role in defining 2026.
Gene Quinn
December 22, 2025, 04:05 PM
1
A Rose by Any Other Name? The Perils of Personal Names as Brand Names
For founders, naming a brand after oneself can feel like the most natural—and powerful—choice. A personal name signifies authenticity, craftsmanship, and accountability. Consumers feel they are not just buying a product, but a person’s vision, values, and reputation. In the apparel, beauty, and skincare space in particular, a founder’s identity often is the brand. That alignment can drive early momentum and deep consumer loyalty. But the same naming strategy that builds value at launch can create significant legal and business complications at scale—especially at exit.
Elizabeth (Liz) Sbardellati
March 5, 2026, 07:15 AM
0
Moderna Settles with Genevant and Arbutus, Ending LNP Patent Dispute
In a press release issued on Tuesday, Genevant Sciences and Arbutus Biopharma announced they have entered into a global settlement with Moderna, Inc. that could result in a payment of up to $2.5 billion. The announcement stated that the settlement resolves all U.S. and international patent litigation concerning the unauthorized use of Genevant’s and Arbutus’ lipid nanoparticle (LNP) delivery technology in Moderna’s COVID-19 vaccines. The agreement came just days before a highly anticipated jury trial was scheduled to begin in the U.S. District Court for the District of Delaware.
Rose Esfandiari
March 4, 2026, 03:15 PM
0
Opinion: Keep Going Squires USPTO: Inventors Want a Streamlined Claim Set Pilot Program 2.0
Under today’s patent system, inventors are only allowed to procure one type of patent—the standard utility patent. Despite the amount of power in the standard utility patent, this restriction oppresses the American inventor. Large numbers of people cannot afford the costs to procure and enforce the standard utility patent, and for many of the ones who can, it often does not pack enough firepower to allow them to fully recover. Because each invention is different, each instance of infringement is different. A single $20,000-$30,000 utility patent is not even close to being capable of addressing every one of those instances. The solution is very simple—different types of patents must be created.
John Powers
March 4, 2026, 08:15 AM
0
Why PTAB Reform Alone Won’t Save the U.S. Patent System | IPWatchdog Unleashed
In the latest episode of IPWatchdog Unleashed, I sat down with my good friends Brad Close, who is the Executive Vice President of Transpacific IP, and Jim Carmichael, a former judge on the Board of Patent Appeals and Interferences and founder of Carmichael IP. Brad, Jim and I engaged in a candid conversation that provides our unvarnished assessment of the Patent Trial and Appeal Board (PTAB), where it started historically, where it is today, and where it may finally be headed. Bottom line: the PTAB is no longer the automatic execution squad it once was, but durable patent rights will require reform well beyond the agency level.
Gene Quinn
January 20, 2026, 09:58 AM
1
Pioneering AI Innovations and Legacy: A Conversation with Inventor Gil Hyatt / IPWatchdog Unleashed
This week on IPWatchdog Unleashed, I sat down with prolific inventor Gil Hyatt, exploring his innovative journey and aspirations to leave a lasting legacy. One of the key highlights of the conversation was Gil’s creation of a non-profit Pioneering AI Foundation, which is aimed at advancing AI technology and bolstering U.S. economic interests. This non-profit organization is set to hold Gil’s substantial portfolio of AI patent applications, which cover his pioneering work dating back to the 1980s, and includes groundbreaking claims in artificial intelligence that could revolutionize sectors like education, manufacturing, and trade.
Gene Quinn
January 13, 2026, 02:15 PM
4
Entrepreneurship, Innovation and Becoming a Patented Inventor: Behind the Scenes with Renee Quinn
This week on IPWatchdog Unleashed, I sat down with my business and life partner, Renee Quinn. In addition to telling Renee’s story about how she found her way into the intellectual property world, and through our sometimes-comical banter, we together explore what it really takes to build, sustain, and continuously reinvent an entrepreneurial company like IPWatchdog. What emerged was a practical roadmap for entrepreneurship, invention, navigating platform risk, and focused on the necessity of constantly being ready to pivot as old business models start to show signs of age and ultimately falter. From Renee’s journey from IP outsider to patented inventor, to firsthand lessons learned navigating Amazon’s reseller ecosystem, the discussion highlights how intellectual property operates in the real world, not the classroom.
Gene Quinn
January 6, 2026, 02:15 PM
1
Latest Podcasts
IPWatchdog Events
IPWatchdog LIVE 2026 at the Renaissance Arlington Capital View
March 22 @ 1:00 pm - March 24 @ 7:00 pm EDT
Industry Events
24th Annual Rocky Mountain Intellectual Property & Technology Law Institute
May 28 @ 8:30 am - May 29 @ 4:30 pm MDT
Subscribe to IPWatchdog
This is the best way to stay informed. We send a daily roundup of our latest news, press releases, and events.
Get Email Updates
Sponsored Content
Recent Podcasts
![[Advertisement]](https://ipwatchdog.com/wp-content/uploads/2021/12/WEBINAR-336-x-280-px.png)
